Ethyl‐eicosapentaenoic acid treatment in Huntington's disease: A placebo‐controlled clinical trial

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 10, 2015-09 ,pp. : 1426-1429

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials

By Allemann Sabin   Diem Peter   Egger Matthias   Christ Emanuel R.   Stettler Christoph  

Current Medical Research and Opinion, Vol. 22, Iss. 3, 2006-03 ,pp. : 617-623

Informa Healthcare

Access to resources Recommend Favorite

Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients: A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis

By Krag Mette   Perner Anders   Wetterslev Jørn   Wise Matt   Hylander Møller Morten  

Intensive Care Medicine, Vol. 40, Iss. 1, 2014-01 ,pp. : 11-22

Springer Publishing Company

Access to resources Recommend Favorite

Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once‐daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double‐blind, placebo‐controlled, clinical trials

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 12, 2015-12 ,pp. : 1496-1507

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is Randomization to Placebo Safe? Risk in Placebo-Controlled Angina Trials: Angina Risk Meta-Analysis

By  

Cardiology, Vol. 120, Iss. 3, 2012-01 ,pp. : 174-181

Karger

Access to resources Recommend Favorite